Van ECK Associates Corp lifted its position in Pfizer Inc. (NYSE:PFE – Free Report) by 33.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,984,150 shares of the biopharmaceutical company’s stock after acquiring an additional 3,265,276 shares during the period. Van ECK Associates Corp owned […]